Header Logo

Connection

BEATRIZ ELENA ADRADA to TOR Serine-Threonine Kinases

Back to Details
This is a "connection" page, showing publications BEATRIZ ELENA ADRADA has written about TOR Serine-Threonine Kinases.
BEATRIZ ELENA ADRADA
Connection Strength
0.035
TOR Serine-Threonine Kinases
  1. Targeting chemotherapy resistance in mesenchymal triple-negative breast cancer: a phase II trial of neoadjuvant angiogenic and mTOR inhibition with chemotherapy. Invest New Drugs. 2023 Jun; 41(3):391-401.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.